We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Minimally Invasive Esophagectomy Improves Survival

By HospiMedica staff writers
Posted on 13 May 2003
The results of the largest study to date evaluating minimally invasive esophagectomy (MIE) to treat esophageal cancer show that the procedure reduces mortality rates and hospital stays compared to most open procedures. More...
These results were reported at the annual meeting of the American Surgical Association in Washington, DC (USA).

Researchers evaluated MIE in 221 patients, comparing hospital stays and mortality rates with similarly sized studies of open methods, including thoracotomy and laparotomy, or both. The results showed that the median hospital stay was seven days for patients with MIE, compared to more than 10 days for patients with open procedures. Also, mortality occurred in 1.3% of the MIE patients, compared to rates of up to 5% or higher reported for open procedures.

MIE is a video-assisted surgical procedure that utilizes instruments introduced into the body through very small incisions and a laparoscope. Patients who are candidates for MIE undergo extensive preoperative evaluation involving laparoscopic staging, endoscopic ultrasound, and computed tomography (CT) scans to assess the extent of the disease.
"Our study demonstrates that minimally invasive esophagectomy offers results as good as, if not better than, open esophageal procedures,” said Dr. James D. Luketich, associate professor of surgery, University of Pittsburgh Medical Center (PA, USA). However, Dr. Luketich stressed that the success of esophagectomy, regardless of method used, largely depends on surgical expertise in the procedure and a high volume of procedures performed annually.





Related Links:
U. of Pittsburgh

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Blood Bank Refrigerator
MBR-705GR-PE
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.